Neurotech International (Australia) Performance
| NTI Stock | 0.07 0 1.45% |
Neurotech International has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.48, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Neurotech International's returns are expected to increase less than the market. However, during the bear market, the loss of holding Neurotech International is expected to be smaller as well. Neurotech International right now secures a risk of 3.77%. Please verify Neurotech International treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside , to decide if Neurotech International will be following its current price movements.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neurotech International are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable forward indicators, Neurotech International is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Last Split Factor 8:7 | Last Split Date 2019-02-01 |
1 | Neurotech International Appoints New CEO to Drive Growth - MSN | 11/21/2024 |
| Begin Period Cash Flow | 5 M |
Neurotech |
Neurotech International Relative Risk vs. Return Landscape
If you would invest 7.10 in Neurotech International on September 1, 2024 and sell it today you would lose (0.10) from holding Neurotech International or give up 1.41% of portfolio value over 90 days. Neurotech International is generating 0.0495% of daily returns assuming 3.7702% volatility of returns over the 90 days investment horizon. Simply put, 33% of all stocks have less volatile historical return distribution than Neurotech International, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Neurotech International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neurotech International's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Neurotech International, and traders can use it to determine the average amount a Neurotech International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0131
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NTI |
Estimated Market Risk
| 3.77 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average Neurotech International is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurotech International by adding it to a well-diversified portfolio.
Neurotech International Fundamentals Growth
Neurotech Stock prices reflect investors' perceptions of the future prospects and financial health of Neurotech International, and Neurotech International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neurotech Stock performance.
| Return On Equity | -0.64 | ||||
| Return On Asset | -0.37 | ||||
| Profit Margin | (1.60) % | ||||
| Operating Margin | 135.32 % | ||||
| Current Valuation | 60.8 M | ||||
| Shares Outstanding | 1.03 B | ||||
| Price To Book | 6.09 X | ||||
| Price To Sales | 22.79 X | ||||
| Revenue | 1.96 K | ||||
| Gross Profit | 1.19 M | ||||
| EBITDA | (8.24 M) | ||||
| Net Income | (5.07 M) | ||||
| Total Debt | 314.7 K | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (4.6 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Total Asset | 12.21 M | ||||
| Retained Earnings | (41.56 M) | ||||
About Neurotech International Performance
Assessing Neurotech International's fundamental ratios provides investors with valuable insights into Neurotech International's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Neurotech International is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Neurotech International is entity of Australia. It is traded as Stock on AU exchange.Things to note about Neurotech International performance evaluation
Checking the ongoing alerts about Neurotech International for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neurotech International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Neurotech International has some characteristics of a very speculative penny stock | |
| Neurotech International had very high historical volatility over the last 90 days | |
| Neurotech International has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1.96 K. Net Loss for the year was (5.07 M) with profit before overhead, payroll, taxes, and interest of 1.19 M. | |
| Neurotech International generates negative cash flow from operations | |
| About 34.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Neurotech International Appoints New CEO to Drive Growth - MSN |
- Analyzing Neurotech International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neurotech International's stock is overvalued or undervalued compared to its peers.
- Examining Neurotech International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Neurotech International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neurotech International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Neurotech International's stock. These opinions can provide insight into Neurotech International's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Neurotech Stock Analysis
When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.